← Back to headlines
Indian Generic Drugs Could Shake Up Global Weight Loss Market
In India, the patent for semaglutide – the active ingredient in Novo Nordisk's Wegovy and Ozempic – is expiring. Will this change the global landscape of obesity treatment?
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Mother and Daughter Die After Rain-Triggered Wall Collapse in Spain
39m ago
Swimming banned in Montenegro's Donja Lastva due to dangerous bacteria levels
44m ago
Chinese Teenagers Turn to Prescription Drugs to Cope with Pressure
49m ago
Motorcyclist Killed in Crash on Athens-Lamia Highway Near Metamorfosi
1h ago